← Leaderboards
Kristen J Nadeau
University Of Colorado Denver
$10,136,353
Attributed
$14,540,000
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,540,000 · 11
By mechanism
U01$7,210,794 · 2
R01$5,772,784 · 2
K23$656,650 · 1
K24$574,455 · 1
R56$214,512 · 1
M01$110,805 · 4
Top collaborators
- Michael A Helmrath5 shared
- Thomas Harris Inge5 shared
- Amy Sanghavi Shah5 shared
- Petter Bjornstad4 shared
- Megan Moriarty Kelsey4 shared
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Kerrie Moreau$13,944,323
- Philip S Zeitler$21,477,687
- Gary L. Pierce$2,308,898
- Ernest E Moore$11,236,991
- Vijaya M. Vemulakonda$744,399
Others in their field
Top investigators on “Insulin Resistance”
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$108,827,660
- C Ronald Kahn · Joslin Diabetes Center$58,520,009
- Leonardo Trasande · New York University School Of Medicine$54,198,824
- Walter N Kernan · Yale University$53,085,019
- Jose A Luchsinger · Columbia University Health Sciences$36,610,547
- Domenico Accili · Columbia University Health Sciences$31,951,136
Research focus
Insulin ResistanceDiabetes MellitusInsulinAdultYouthNon-Insulin-Dependent Diabetes MellitusObesityInsulin SensitivityPositioning AttributeGlycemic ControlAdolescentInsulin SecretionChildhoodMetforminFunctional DisorderInnovationCardiovascular DiseasesMorbidity - Disease RateResponseBeta CellCell PhysiologyFutureDiabetic NephropathyPharmaceutical Preparations
Grant awards (35)
What Activates Type 2 diabetes in Children (WATCH)$629,905
U01 · FY2025 · DK · contact PI
Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes (T1-DISCO)$598,776
R01 · FY2025 · HL · contact PI
What Activates Type 2 diabetes in Children (WATCH)$632,519
U01 · FY2024 · DK · contact PI
Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes (T1-DISCO)$610,712
R01 · FY2024 · HL · contact PI
What Activates Type 2 Diabetes in Children (WATCh)?$59,239
U01 · FY2024 · DK · contact PI
Surgical or Medical Treatment for Pediatric Type 2 Diabetes (ST2OMP)$647,956
R01 · FY2023 · DK
Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes (T1-DISCO)$619,880
R01 · FY2023 · HL · contact PI
The Next Generation of Innovative Cardiovascular Clinical/Translational Researchers$114,891
K24 · FY2023 · HL · contact PI
What Activates Type 2 diabetes in Children (WATCH)$50,205
U01 · FY2023 · DK · contact PI
Surgical or Medical Treatment for Pediatric Type 2 Diabetes (ST2OMP)$655,729
R01 · FY2022 · DK
Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes (T1-DISCO)$618,131
R01 · FY2022 · HL · contact PI
The Next Generation of Innovative Cardiovascular Clinical/Translational Researchers$114,891
K24 · FY2022 · HL · contact PI
Surgical or Medical Treatment for Pediatric Type 2 Diabetes (ST2OMP)$661,485
R01 · FY2021 · DK
The Next Generation of Innovative Cardiovascular Clinical/Translational Researchers$114,891
K24 · FY2021 · HL · contact PI
Surgical or Medical Treatment for Pediatric Type 2 Diabetes (ST2OMP)$669,713
R01 · FY2020 · DK
The Next Generation of Innovative Cardiovascular Clinical/Translational Researchers$114,891
K24 · FY2020 · HL · contact PI
Surgical or Medical Treatment for Pediatric Type 2 Diabetes (ST2OMP)$690,402
R01 · FY2019 · DK
The Next Generation of Innovative Cardiovascular Clinical/Translational Researchers$114,891
K24 · FY2019 · HL · contact PI
RISE: The Restoring Insulin Secretion Pediatric Medication Study$1,487,860
U01 · FY2015 · DK · contact PI
RISE: The Restoring Insulin Secretion Pediatric Medication Study$509,997
U01 · FY2015 · DK · contact PI
RISE: The Restoring Insulin Secretion Pediatric Medication Study$721,547
U01 · FY2014 · DK · contact PI
Beta-Cell Rescue in Youth with New Onset T2DM$1,010,477
U01 · FY2013 · DK · contact PI
Beta-Cell Rescue in Youth with New Onset T2DM$1,061,467
U01 · FY2012 · DK · contact PI
Beta-Cell Rescue in Youth with New Onset T2DM$711,830
U01 · FY2011 · DK · contact PI
Beta-cell Rescue in Youth with New Onset T2DM$335,748
U01 · FY2011 · DK · contact PI
Insulin Resistance In Adolescents With Diabetes: A New Frontier For Cardiovascula$214,512
R56 · FY2010 · DK · contact PI
Insulin Control of Fat Regulation and Exercise in Teens$131,330
K23 · FY2008 · RR · contact PI
Insulin Control of Fat Regulation and Exercise in Teens$131,330
K23 · FY2007 · RR · contact PI
INSULIN SENSITIVITY IN ADOLESCENTS WITH DIABETES$35,435
M01 · FY2007 · RR · contact PI
EXERCISE CAPACITY IN PEDIATRIC OBESITY AND TYPE 2 DIABETES$13,288
M01 · FY2007 · RR · contact PI
Insulin Control of Fat Regulation and Exercise in Teens$131,330
K23 · FY2006 · RR · contact PI
EXERCISE CAPACITY IN PEDIATRIC OBESITY AND TYPE 2 DIABETES$54,007
M01 · FY2006 · RR · contact PI
Insulin Control of Fat Regulation and Exercise in Teens$131,330
K23 · FY2005 · RR
EXERCISE CAPACITY IN PEDIATRIC OBESITY AND TYPE 2 DIABETES$8,075
M01 · FY2005 · RR
Insulin Control of Fat Regulation and Exercise in Teens$131,330
K23 · FY2004 · RR